These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25367614)

  • 1. CYP 2C19 and UDP-glucuronosyltransferases not only for drugs but also for endobiotics.
    Siest G; Fournel-Gigleux S; Magdalou J
    Drug Metabol Drug Interact; 2014; 29(4):207-9. PubMed ID: 25367614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent data on the metabolism of drugs by UDP-glucuronosyltransferases and sulfotransferases (author's transl)].
    Batt AM; Magdalou J; Martin N; Lepage C; Kiffel L; Siest G
    Ann Biol Clin (Paris); 1980; 38(1):35-47. PubMed ID: 6769373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase.
    Anderson GD
    J Gend Specif Med; 2002; 5(1):25-33. PubMed ID: 11859684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [UDP-glucuronosyltransferases and glucuronoconjugation].
    Siest G; Boutin JA; Magdalou J; Batt AM; Antoine B; Fournel S; Thomassin J
    Therapie; 1985; 40(3):139-53. PubMed ID: 3925586
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of hepatocytes to investigate UDP-glucuronosyltransferases and sulfotransferases.
    Fournel-Gigleux S; Coughtrie MW; Ouzzine M; Magdalou J
    Methods Mol Biol; 2010; 640():309-26. PubMed ID: 20645060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators.
    Knights KM; Miners JO
    Drug Metab Rev; 2010 Feb; 42(1):63-73. PubMed ID: 19780654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights.
    Tripathi SP; Bhadauriya A; Patil A; Sangamwar AT
    Drug Metab Rev; 2013 May; 45(2):231-52. PubMed ID: 23461702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions.
    Bock KW; Köhle C
    Biochem Pharmacol; 2009 May; 77(9):1458-65. PubMed ID: 19150343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.
    Kaivosaari S; Finel M; Koskinen M
    Xenobiotica; 2011 Aug; 41(8):652-69. PubMed ID: 21434773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrochemically driven drug metabolism via a CYP1A2-UGT1A10 bienzyme confined in a graphene nano-cage.
    Lu J; Zhang Y; Li H; Yu J; Liu S
    Chem Commun (Camb); 2014 Nov; 50(90):13896-9. PubMed ID: 25264962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.
    Williams JA; Hyland R; Jones BC; Smith DA; Hurst S; Goosen TC; Peterkin V; Koup JR; Ball SE
    Drug Metab Dispos; 2004 Nov; 32(11):1201-8. PubMed ID: 15304429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Kiang TK; Ensom MH; Chang TK
    Pharmacol Ther; 2005 Apr; 106(1):97-132. PubMed ID: 15781124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical demonstration of isozyme- and strain-specific differences in the intralobular localizations and distributions of UDP-glucuronosyltransferases in livers of untreated rats.
    Knapp SA; Green MD; Tephly TR; Baron J
    Mol Pharmacol; 1988 Jan; 33(1):14-21. PubMed ID: 3122018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing pediatric dosing: a developmental pharmacologic approach.
    Anderson GD; Lynn AM
    Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
    Deguchi T; Watanabe N; Kurihara A; Igeta K; Ikenaga H; Fusegawa K; Suzuki N; Murata S; Hirouchi M; Furuta Y; Iwasaki M; Okazaki O; Izumi T
    Drug Metab Dispos; 2011 May; 39(5):820-9. PubMed ID: 21282406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
    Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
    Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of UDP- glucuronosyltransferase (UGT) activities.
    Coffman BL; Rios GR; Tephly TR
    Curr Protoc Toxicol; 2002; Chapter 4():Unit4.3. PubMed ID: 23045083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytochrome P450 and UDP-glucuronosyltransferases in metabolic pathway of homoegonol in human liver microsomes.
    Kwon SS; Kim JH; Jeong HU; Ahn KS; Oh SR; Lee HS
    Drug Metab Pharmacokinet; 2015 Aug; 30(4):305-13. PubMed ID: 26163112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug metabolism in the paediatric population and in the elderly.
    Benedetti MS; Whomsley R; Canning M
    Drug Discov Today; 2007 Aug; 12(15-16):599-610. PubMed ID: 17706541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
    Wells PG; Mackenzie PI; Chowdhury JR; Guillemette C; Gregory PA; Ishii Y; Hansen AJ; Kessler FK; Kim PM; Chowdhury NR; Ritter JK
    Drug Metab Dispos; 2004 Mar; 32(3):281-90. PubMed ID: 14977861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.